Endothelial dysfunction in COVID-19 calls for immediate attention: the emerging roles of the endothelium in inflammation caused by SARS-CoV-2.
10.1007/s11684-021-0831-z
- Author:
Weijian HANG
1
;
Chen CHEN
1
;
Xin A ZHANG
2
;
Dao Wen WANG
3
Author Information
1. Division of Cardiology, Department of Internal Medicine, and Hubei Key Laboratory of Genetics and Molecular Mechanisms of Cardiological Disorders, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China.
2. Department of Physiology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, 73104, USA.
3. Division of Cardiology, Department of Internal Medicine, and Hubei Key Laboratory of Genetics and Molecular Mechanisms of Cardiological Disorders, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China. dwwang@tjh.tjmu.edu.cn.
- Publication Type:Journal Article
- Keywords:
COVID-19;
cytokine storm;
endothelial dysfunction;
inflammation reaction
- MeSH:
COVID-19;
Endothelium;
Humans;
Inflammation;
Pandemics;
SARS-CoV-2
- From:Frontiers of Medicine
2021;15(4):638-643
- CountryChina
- Language:English
-
Abstract:
The COVID-19 pandemic has caused numerous deaths around the world. A growing body of evidence points to the important role of overwhelming inflammatory responses in the pathogenesis of COVID-19 and the effectiveness of anti-inflammation therapy against COVID-19 is emerging. In addition to affecting the lungs, COVID-19 can be a severe systemic inflammatory disease that is related to endothelial dysfunction. We are calling for closer attention to endothelial dysfunction in COVID-19 not only for fully revealing the pathogenic mechanism of COVID-19 but also for properly adjusting the strategy of clinical intervention.
